FMP

FMP

Enter

ASLN - ASLAN Pharmaceutical...

Financial Summary of ASLAN Pharmaceuticals Limited(ASLN), ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engage

photo-url-https://financialmodelingprep.com/image-stock/ASLN.png

ASLAN Pharmaceuticals Limited

ASLN

NASDAQ

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

0.445 USD

-0.0148 (-3.33%)

About

ceo

Dr. Carl Alan Jason Morton Firth EMBA, Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://aslanpharma.com

exchange

NASDAQ

Description

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was fou...

CIK

0001722926

ISIN

US04522R2004

CUSIP

04522R101

Address

83 Clemenceau Avenue

Phone

65 6222 4235

Country

SG

Employee

35

IPO Date

May 4, 2018

Summary

CIK

0001722926

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

04522R101

ISIN

US04522R2004

Country

SG

Price

0.45

Beta

1.52

Volume Avg.

1.27M

Market Cap

10.07M

Shares

-

52-Week

0.392-4.26

DCF

0.03

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.22

P/B

-

Website

https://aslanpharma.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ASLN News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep